Company intelligence / Profile preview

PathSensors

Baltimore, Maryland, United States

Ownership: Private
Employees: ~20
Development stage: Other

Overview

PathSensors developed and commercialized CANARY biosensor-based instruments (such as BioFlash and Zephyr) for ultra-rapid detection of a broad range of bacterial, viral, and toxin pathogens in environmental, food, and agricultural samples; these are commercial diagnostic tools, not therapeutics or clinical-stage drugs.[1][3][4]

Therapeutic areas: Infectious Diseases
Modalities: Device
Industry: Non-Drug Biotech

Partnerships

MIT Lincoln Laboratory (CANARY technology licensing)[1][4]Maryland Department of Business and Economic Development / BioMaryland Center (funding and support)[1]US government agencies and first responder organizations for deployment of Zephyr field systems[1]US federal Small Business Innovation Research (SBIR) program for food-borne pathogen detection instrument development[4]

Beyond the preview

Go deeper on PathSensors.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PathSensors.

Explore the full profile